Northwest & Ethical Investments L.P.
Position in CAI — Caris Life Sciences, Inc.
CIK 2033536
TORONTO, A6
Position in CAI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$84,235
-$139,265 QoQ
Shares Held
4,727
-62.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#181
of 246 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CAI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Northwest & Ethical Investments L.P. holds $4,060,177 across 9 Biotechnology names. CAI ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,664 | $3,310,208 | |
| 2 | QURE |
uniQure N.V.
|
2,823 | $130,027 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,100 | $122,133 | |
| 4 | ZYME |
Zymeworks Inc.
|
4,630 | $121,028 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
896 | $104,894 | |
| 6 | CAI |
Caris Life Sciences, Inc.
This page
|
4,727 | $84,235 | |
| 7 | CGON |
CG Oncology, Inc.
|
1,185 | $84,194 | |
| 8 | ABVX |
Abivax S.A.
|
467 | $62,232 |
All Filings in CAI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,235 | 4,727 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $223,500 | 12,500 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $285,988 | 10,600 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||